NMRK Stock Analysis: Newmark | NASDAQ
Real Estate Services | NASDAQ, USA | Market Cap: 3.967m USD | 12M Return: -11.5% | US65158N1028 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 19.7M
EPS Trend: 99.3%
Qual. Beats: 0
Rev. Trend: 99.1%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 8.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Newmark Group, Inc. (NASDAQ: NMRK) is a global commercial real estate advisory and services firm headquartered in New York, founded in 1929 and operating as a subsidiary of Cantor Fitzgerald, L.P. The company provides a broad range of fee-based services across capital markets (investment sales, debt placement, GSE/FHA lending, structured finance), leasing (landlord and tenant representation), loan servicing and asset management, valuation and advisory, property management, workspace solutions, occupier services, and a commercial real estate technology platform. Its clients span tenants, investors, owners, occupiers, developers, lenders, small and medium-sized businesses, multinational corporations, and institutional real estate owners across the United States, the United Kingdom, Asia, rest of Europe, and other Americas.
The company is classified within the Real Estate sector (Real Estate Development sub-industry) under the GICS framework and trades as a mid-cap stock following its December 2017 IPO. Unlike traditional real estate developers, Newmark generates revenue primarily through transaction commissions, advisory fees, and recurring management/servicing fees rather than direct property ownership, positioning it as a capital-light services business. The firms historical use of the Knight Frank brand reflects a longstanding international affiliation with the global Knight Frank real estate network.
- Capital markets deal volume pressured by elevated interest rates
- GSE multifamily loan servicing expands recurring fee revenue
- Tenant representation and occupier services tied to corporate demand
| Net Income: 148.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 20.14 > 1.0 |
| NWC/Revenue: 5.00% < 20% (prev 2.84%; Δ 2.15% < -1%) |
| CFO/TA 0.16 > 3% & CFO 846.0m > Net Income 148.2m |
| Net Debt (2.41b) to EBITDA (497.8m): 4.84 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (253.9m) vs 12m ago 0.11% < -2% |
| Gross Margin: 94.97% > 18% (prev 100.0%; Δ -5.03% > 0.5%) |
| Asset Turnover: 68.16% > 50% (prev 55.35%; Δ 12.81% > 0%) |
| Interest Coverage Ratio: 4.84 > 6 (EBIT TTM 311.2m / Interest Expense TTM 64.3m) |
| A: 0.03 (Total Current Assets 2.10b - Total Current Liabilities 1.92b) / Total Assets 5.19b |
| B: 0.26 (Retained Earnings 1.33b / Total Assets 5.19b) |
| C: 0.06 (EBIT TTM 311.2m / Avg Total Assets 5.29b) |
| D: 0.42 (Book Value of Equity 1.45b / Total Liabilities 3.44b) |
| Altman-Z'' = 1.90 = BBB |
| DSRI: 0.91 (Receivables 660.1m/598.7m, Revenue 3.61b/2.98b) |
| GMI: 1.05 (GM 100.0% / 94.97%) |
| AQI: 1.09 (AQ_t 0.49 / AQ_t-1 0.44) |
| SGI: 1.21 (Revenue 3.61b / 2.98b) |
| TATA: -0.13 (NI 148.2m - CFO 846.0m) / TA 5.19b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of August 30, 2026, the stock is trading at USD 15.83 with a total of 1,195,835 shares traded. Over the past week, the price has changed by -2.34%, over one month by -1.87%, over three months by +11.45% and over the past year by -11.51%.
Current recommended Stop Loss: 14.50 (which is 8.4% or 2.5 ATR below the current price).
Newmark has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy NMRK.
- StrongBuy: 1
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 19.8 | 24.8% |
P/E Trailing = 20.0123
P/E Forward = 5.7405
P/S = 1.1007
P/B = 2.0449
Revenue TTM = 3.61b USD
EBIT TTM = 311.2m USD
EBITDA TTM = 497.8m USD
Long Term Debt = 867.3m USD (from longTermDebt, last quarter)
Short Term Debt = 909.1m USD (from shortTermDebt, last quarter)
Debt = 2.67b USD (from shortLongTermDebtTotal, last quarter) + Leases 494.7m
Net Debt = 2.41b USD (calculated: Debt 2.67b - CCE 259.7m)
Enterprise Value = 6.38b USD (3.97b + Debt 2.67b - CCE 259.7m)
Interest Coverage Ratio = 4.84 (Ebit TTM 311.2m / Interest Expense TTM 64.3m)
EV/FCF = 7.99x (Enterprise Value 6.38b / FCF TTM 797.6m)
FCF Yield = 12.51% (FCF TTM 797.6m / Enterprise Value 6.38b)
FCF Margin = 22.12% (FCF TTM 797.6m / Revenue TTM 3.61b)
Net Margin = 4.11% (Net Income TTM 148.2m / Revenue TTM 3.61b)
Gross Margin = 94.97% ((Revenue TTM 3.61b - Cost of Revenue TTM 181.3m) / Revenue TTM)
Gross Margin QoQ = 94.82% (prev 94.54%)
Tobins Q-Ratio = 1.23 (Enterprise Value 6.38b / Total Assets 5.19b)
Interest Expense / Debt = 2.41% (Interest Expense 64.3m / Debt 2.67b)
Taxrate = 26.30% (64.9m / 246.8m)
NOPAT = 229.3m (EBIT 311.2m * (1 - 26.30%))
Current Ratio = 1.09 (Total Current Assets 2.10b / Total Current Liabilities 1.92b)
Debt / Equity = 1.84 (Debt 2.67b / totalStockholderEquity, last quarter 1.45b)
Debt / EBITDA = 4.84 (Net Debt 2.41b / EBITDA 497.8m)
Debt / FCF = 3.02 (Net Debt 2.41b / FCF TTM 797.6m)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.80% (Net Income 148.2m / Total Assets 5.19b)
RoE = 10.45% (Net Income TTM 148.2m / Total Stockholder Equity 1.42b)
RoCE = 13.61% (EBIT 311.2m / Capital Employed (Equity 1.42b + L.T.Debt 867.3m))
RoIC = 5.74% (NOPAT 229.3m / Invested Capital 4.00b)
WACC = 6.84% (E(3.97b)/V(6.64b) * Re(10.24%) + D(2.67b)/V(6.64b) * Rd(2.41%) * (1-Tc(0.26)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 43.60 | Cagr: 18.06%
[DCF] Terminal Value 75.44% ; FCFF base≈797.6m ; Y1≈800.9m ; Y5≈848.4m
[DCF] Fair Price = 67.44 (EV 13.2b - Net Debt 2.41b = Equity 10.8b / Shares 159.9m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 99.31 | EPS CAGR: 26.95% | SUE: -0.43 | # QB: 0
Revenue Correlation: 99.09 | Revenue CAGR: 17.19% | SUE: 0.71 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.48 | Chg30d=-1.75% | Revisions=-17% | Analysts=6
EPS current Year (2026-12-31): EPS=1.95 | Chg30d=+0.93% | Revisions=+29% | GrowthEPS=+20.5% | GrowthRev=+16.6%
EPS next Year (2027-12-31): EPS=2.21 | Chg30d=+2.11% | Revisions=+38% | GrowthEPS=+13.0% | GrowthRev=+9.2%
[Analyst] Revisions Ratio: +27% (up=8, down=4)